Rodman & Renshaw

Rodman & Renshaw initiates coverage on Ligand Pharmaceuticals (Nasdaq: LGND) with a Market Outperform. Price target $5.

Rodman analyst ...

NEW YORK, NY -- (MARKET WIRE) -- 11/19/08 -- Tongli Pharmaceuticals (OTCBB: TGLP), a pharmaceutical company specializing in development, manufacture, and commercialization of a wide range of prescription and over the counter ("OTC") pharmaceutical products, today announced financial results for the quarter ended September 30, 2008. Financial Results Revenue in the second quarter of fiscal year 2009 increased 298% year over year to $1,645,540 from $413,034, and revenues in the six months ended September 30, 2008 increased 328% year over year to $3,310,710 from $773,574, reflecting an increase in product demand attributable to increased brand recognition, effective pricing strategy and penetration into previously unaddressed markets. Gross profit in the second quarter of fiscal year 2009 increased 306% to $718,721 from $177,144 in the same period of 2007. Gross margin was approximately 43.7%, compared to 42.9% in the same period of the prior year. Gross profit in the six months ended September 30, 2008 increased 329% to $1,413,751 from $328,850 in the same period of 2007 ...

Rodman & Renshaw upgrades IDM Pharma (Nasdaq: IDMI) from Market Underperform to Market Perform.

Rodman analyst says, "This morning, IDM Pharma announced that the Committee for Medicinal ...

Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) sees insider buying. After the close, CEO ...

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 14, 2008) - Adanac Molybdenum Corporation ("Adanac or the Company") (TSX: AUA)(PINK SHEETS: AUAYF)(FRANKFURT: A9N) announces that on November 11, 2008, Peter Jones, Chairman and CEO, made a presentation on Adanac and its Ruby Creek Project at the Rodman and Renshaw Conference in New York City, New York. To view the presentation, please visit our website at www.adanacmoly.com and access "Adanac Management Presentation" on the splash page. Adanac continues to reconstruct its website and expects the addition of "menu and inner pages" shortly. About Adanac Molybdenum Corporation Adanac Molybdenum Corporation is listed on the TSX and Frankfurt exchanges and owns the Ruby Creek Molybdenum Project in Northern British Columbia. The Company has advanced the project through feasibility studies, a production decision and ...